About
NXgenPort develops implantable chemotherapy ports integrated with optical sensing and machine learning to remotely monitor blood cell dynamics and detect treatment complications early in cancer patients.
Explore NXgenPort's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.